Zhejiang CONBA Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang CONBA Pharmaceutical Co Ltd financial flexibility index. Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥160.33 Million (operating CF CN¥133.43 Million minus capex CN¥26.90 Million) represents 0% of total liabilities (CN¥2.97 Billion). See Zhejiang CONBA Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Financial flexibility index of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Check 600572 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Zhejiang CONBA Pharmaceutical Co Ltd Financial Flexibility Index by Year (2003–2025)
Zhejiang CONBA Pharmaceutical Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang CONBA Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang CONBA Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥1.09 Billion | CN¥942.61 Million | CN¥2.83 Billion | ▼ -11.7% |
| 2024 | 0.44x | CN¥1.30 Billion | CN¥1.01 Billion | CN¥2.99 Billion | ▲ +53.0% |
| 2023 | 0.28x | CN¥1.11 Billion | CN¥898.64 Million | CN¥3.89 Billion | ▼ -29.0% |
| 2022 | 0.40x | CN¥1.45 Billion | CN¥1.16 Billion | CN¥3.61 Billion | ▼ -6.4% |
| 2021 | 0.43x | CN¥1.46 Billion | CN¥889.94 Million | CN¥3.40 Billion | ▼ -1.5% |
| 2020 | 0.44x | CN¥1.71 Billion | CN¥1.25 Billion | CN¥3.93 Billion | ▲ +79.2% |
| 2019 | 0.24x | CN¥1.19 Billion | CN¥925.50 Million | CN¥4.92 Billion | ▲ +29.1% |
| 2018 | 0.19x | CN¥925.41 Million | CN¥545.78 Million | CN¥4.92 Billion | ▼ -33.0% |
| 2017 | 0.28x | CN¥1.00 Billion | CN¥712.27 Million | CN¥3.58 Billion | ▼ -6.4% |
| 2016 | 0.30x | CN¥1.20 Billion | CN¥969.71 Million | CN¥4.01 Billion | ▲ +34.2% |
| 2015 | 0.22x | CN¥1.12 Billion | CN¥831.26 Million | CN¥5.00 Billion | ▼ -37.5% |
| 2014 | 0.36x | CN¥1.05 Billion | CN¥617.43 Million | CN¥2.93 Billion | ▼ -6.5% |
| 2013 | 0.38x | CN¥711.68 Million | CN¥235.36 Million | CN¥1.86 Billion | ▲ +65.1% |
| 2012 | 0.23x | CN¥485.52 Million | CN¥245.76 Million | CN¥2.10 Billion | ▼ -2.9% |
| 2011 | 0.24x | CN¥321.45 Million | CN¥188.36 Million | CN¥1.35 Billion | ▼ -25.5% |
| 2010 | 0.32x | CN¥239.00 Million | CN¥125.93 Million | CN¥747.34 Million | ▲ +20.8% |
| 2009 | 0.26x | CN¥206.72 Million | CN¥153.39 Million | CN¥780.76 Million | ▼ -4.3% |
| 2008 | 0.28x | CN¥179.67 Million | CN¥98.56 Million | CN¥649.60 Million | ▲ +18.5% |
| 2007 | 0.23x | CN¥161.81 Million | CN¥79.98 Million | CN¥693.32 Million | ▲ +7.1% |
| 2006 | 0.22x | CN¥136.87 Million | CN¥71.20 Million | CN¥628.20 Million | ▼ -47.9% |
| 2005 | 0.42x | CN¥234.22 Million | CN¥117.65 Million | CN¥560.55 Million | ▲ +34.6% |
| 2004 | 0.31x | CN¥129.28 Million | CN¥65.47 Million | CN¥416.37 Million | ▼ -0.7% |
| 2003 | 0.31x | CN¥106.98 Million | CN¥66.64 Million | CN¥342.22 Million | — |